Filtered library · Theme
M&A & special situations theme · 96 dossiers
Dossiers in the M&A & special situations theme cluster — 96 names moving on shared catalysts.
All dossiers IRDM Iridium Communications Inc fresh MEDIUM Deal-arb: $27.00 cash plus a collared RKLB stock leg marks a $54.00 package against the 2026-08-24 close of $47.30, a 12.41% discount. The S-4/A filed 2026-08-24 finally dated the special meeting (2026-09-24), but RKLB at $68.28 sits just… XPO XPO, Inc. fresh LOW Record 79.9% adjusted LTL operating ratio and a raised full-year guide (2026-07-30) now sit against two negative July industry prints — ATA tonnage -0.5% YoY and Cass shipments -4.8% YoY. The $197.01 shelf gave way on the 2026-08-24 close… MRX Marex Group plc HIGH Roll-up compounder in clean momentum continuation: the sell-side is now chasing price, with KBW $80, Barclays $76 and Piper $75 targets (Jul 9-15) leapfrogging the old $60 consensus, while the Bright Point clearing bolt-on (2026-07-09)… ACIW ACI Worldwide, Inc. MEDIUM Special-situation breakup narrative accelerating: Reuters (2026-07-17) reports ACI exploring a ~$1.5B sale of its Biller unit, which would surface sum-of-the-parts value and re-rate the faster-growing Payments Software segment. Q1 beat +… ACLS Axcelis Technologies, Inc. MEDIUM Beat-and-raise on 2026-08-06 (Q2 rev $215.175M vs $204.985M est; Q3 guided $230.0M vs $214.846M) repaired the fundamental case, but price only recovered to the top of the July band at $140.15 (08-14), 26.9% under the $191.6 high. China… BH Biglari Holdings Inc. MEDIUM Q2 10-Q (filed 2026-08-07) answered the dilution question early: six-month issuance proceeds of $14,920k do not exceed the $15,073k of ATM sales already disclosed through 2026-05-08, so nothing material was sold into the June run to… BMY Bristol-Myers Squibb Co. MEDIUM Legacy-pharma re-rate off the 2026-07-30 guidance reset ($49.0–50.0B sales, $6.75–7.00 adj EPS) is intact, but both attention legs are spent: the AstraZeneca merger was denied 2026-08-05 and the FDA approved ZENBEXUS on 2026-08-13, four… CCC CCC Intelligent Solutions Holdings Inc. MEDIUM Cheap, high-margin insurtech SaaS put in play: a Morgan Stanley-run sale process plus a fresh Elliott activist stake. Shares popped ~13% to ~$6 on the 2026-07-09 Reuters report yet still sit below a plausible PE take-out. The trade is… CODI Compass Diversified MEDIUM Q2 (2026-08-10) reframed the name: adj EPS $(0.09) missed $0.09 est, but Subsidiary Adj EBITDA rose 12.6% to $91.5M and covenant leverage fell 5.3x to 4.8x. TD Cowen went $12.50→$18. Riley upgraded to Buy at $15 on 2026-08-11; three… DINO HF Sinclair Corporation MEDIUM Post-print leg extended rather than renewed: a fresh 52-week high at $97.32 (2026-08-21), +40.1% over three months, built on the 2026-07-28 beat ($5.31 vs $4.54), the Lubricants spin-off plan and the 2026-08-11 $5B Western Gateway FID.… FA First Advantage Corporation MEDIUM Aug 6 flipped the frame: Q2 revenue $448.8M/+14.9% vs $415.0M consensus, adj EPS $0.35 vs $0.28, and the first FY guide raise of the cycle ($1.67–1.71B). Needham upgraded to Buy/$28, RBC to $24 — targets moved above spot for the first… HPP Hudson Pacific Properties, Inc. MEDIUM The refi binary now has a filed date: the 10-Q (2026-08-10) puts the Hollywood Media Portfolio loan maturity at 2026-09-09 with the longer-term extension still unresolved. Q2 beat ($0.35 Core FFO vs $0.26) and three August target raises… IDYA IDEAYA Biosciences, Inc. MEDIUM Approval leg intact but between catalysts: the OptimUM-02 win (HR 0.42, ASCO 2026-06-01) feeds a rolling NDA under FDA RTOR guided complete H2 2026, and Q2 (2026-08-04) showed ~$1.24B cash with runway into 2030. Nothing company-dated until… ILMN Illumina, Inc. MEDIUM Post-print give-back fully reversed: $187.96 on 2026-08-07 to a 52-week-high close of $219.40 on 2026-08-21 (+51.9% over three months, RSI 66.3) with no new operating news since the 2026-07-30 beat-and-raise. Price now sits above the… KODK Eastman Kodak Company MEDIUM AM&C inflection is now the entire story: the 2026-08-04 Q2 print put segment revenue at $105M (+40% YoY) and consolidated operational EBITDA at $36M vs $9M, and the ~$9.20 shelf reclaimed on that print has held — the 2026-08-21 close was… NEOG Neogen Corporation MEDIUM Post-3M-integration cleanup is in the numbers after the 2026-07-30 beat-and-raise, but the re-rating has stopped extending: $11.95 close on 2026-08-21, a marginal new high at $12.15, RSI 50.8, no target change since Piper Sandler's $13 on… NKTR Nektar Therapeutics MEDIUM M&A read-through re-accelerating: AbbVie's $10.9B Apogee buyout (June 22, 2026) reframed NKTR as the next takeout-able Treg-IL-2 atopic-dermatitis asset, driving a ~25% run off the June low to ~$70. It's sympathy optionality, not fresh… OXM Oxford Industries, Inc. MEDIUM Setup inverted since the June breakdown. OXM reclaimed its 200-day ($39.11) and 50-day ($39.94) off the $35.83 low, the CEO bought 2,500 shares at $36.90 on 2026-06-12, and ~$25M of filed IEEPA tariff-refund claims — 4% of market cap,… PD PagerDuty, Inc. MEDIUM The read has flipped from value trap to ownership story. Price reclaimed the 200-DMA (~$10.30 on 2026-07-17, +13% in three weeks), Truist lifted its PT to $11 on 2026-07-09, and the 2026-07-14 addition of Alex Shootman — who sold Workfront… PRGS Progress Software Corporation MEDIUM Disciplined software roll-up ("Total Growth Strategy") re-rated by a fresh catalyst cluster: Q2 beat + FY guide raise (2026-06-30) and the $400M Domo buy (2026-07-22). Special-situations theme active, but a maturing low-beta compounder —… PRM Perimeter Solutions, Inc. MEDIUM Monopoly wildfire retardant (PHOS-CHEK) into a season at national Preparedness Level 5 — 3.85M acres burned YTD (NIFC, 7/18), ~157% of the 10-yr average. JPM initiated Overweight $50 on 7/9, lifting the 4-analyst average target to $45.… RMAX Re/Max Holdings, Inc. fresh MEDIUM Merger arb that finally got a date. DOJ granted HSR early termination 2026-07-13 and both special meetings are set for 2026-08-14, removing the regulatory leg. RMAX $11.10 vs ~$11.86 blended (5.150 REAX at $2.21 plus the prorated $13.80… ACB Aurora Cannabis Inc. LOW Frame flipped 2026-08-11: Curaleaf's unsolicited proposal — 0.3463 CURLF shares + US$0.75 cash, implied US$4.00, capped at US$5.00 — turned a broken Canadian LP into a live take-over situation. No formal bid has been commenced, the board… ACHR Archer Aviation Inc. LOW The 2026-08-10 Boeing-subsidiary re-rating has fully retraced: the 2026-08-21 weekly close of $6.30 sits 0.6% above the $6.26 pre-announcement reference, so the market is valuing >$200M of acquired Insitu revenue at roughly nothing. ALOT AstroNova, Inc. LOW Terminal merger-arb pin. Arcline's $29.00 all-cash take-private cleared its HSR condition on 2026-07-31 and goes to a shareholder vote on 2026-08-25; the 2026-08-14 close of $28.91 leaves $0.09 of gross spread against a break tail toward… ANAB AnaptysBio, Inc. LOW The dateless wait acquired a docket: a 2026-07-28 stipulation set post-trial briefing to an Oct 20 Chancery argument, and ANAB has rebuilt from ~$54 (Jul 24) to $58.47 (Aug 14) on no company news. The written opinion deciding Jemperli… APGE Apogee Therapeutics, Inc. LOW HSR expiry (2026-08-05) and shareholder approval (2026-08-11) cleared the last stated conditions on AbbVie's $135.11 all-cash takeout, so what trades now is terminal merger-arb carry into a company-guided Q3-2026 close — capped at the bid,… ARX Accelerant Holdings LOW Signed all-cash take-private at $20.25; the 2026-08-21 close of $19.59 leaves a fixed-price insurance-regulatory arb with the ceiling contractually set. Newly visible merger terms — go-shop ending 2026-09-22, outside date 2027-08-13… ATAI AtaiBeckley Inc. LOW Lilly takeout is now a process, not a story: DEFM14A filed, special meeting 2026-09-08, HSR filed 2026-07-29, close guided Q3 2026. The 2026-08-14 close of $7.26 sits $0.51 over the $6.75 cash leg, so all remaining return is an unread CVR… AVNS Avanos Medical, Inc. LOW Resolved, not pending: AIP completed the $25.00/share all-cash take-private on 2026-07-27 and AVNS ceased NYSE trading the same day (EV ~$1.272B). Holders received cash; there is no listed security, no narrative leg and no catalyst left.… AZTA Azenta, Inc. LOW No new company information since the Aug 4 print, yet price ran from $33.39 (Aug 11) to $37.40 (Aug 21) with RSI(14) at 81.5 and the six-analyst consensus target of $34.80 now below spot. The self-help leg ($529M cash, no debt, $50.0M… BAK Braskem S.A. LOW Q2 2026 (released 2026-08-14) printed US$1.043B recurring EBITDA on a Middle East supply shock management called tactical — and the ADR closed $1.95, pricing the capital structure rather than the P&L. The 2026-06-26 São Paulo shield… BOLD Boundless Bio, Inc. LOW Merger-arb wrapper, not an oncology stock: the object is a planned $44–48M pre-close cash dividend plus a 3.69% stub in the AATD base-editing NewCo. Week of 2026-08-14 added owners (ADAR1 13G at 8.8%) but no deal documents — still no S-4,… BTGO BitGo Holdings, Inc. LOW Broken IPO that cleared its 2026-07-21 lockup without a supply flood but is grinding on the $4.665 all-time low with no bounce; Goldman cut its target to $7.75, and the undated $100M Galaxy verdict plus the ~2026-08-26 Q2 print are the… BWMN Bowman Consulting Group Ltd. LOW Not a growth story — a cash-deal spread. Bernhard Capital's $43.00 all-cash take-private (signed 2026-08-10) caps the name; the 2026-08-21 close of $42.61 is $0.39 under it, down from a $0.70 gap on 2026-08-14. The go-shop expires 5:00… CBZ CBIZ, Inc. LOW Deal-completion story now, not an operating one: the 2026-08-21 close of $54.66 sits $0.34 under the signed $55.00 all-cash terms, in from $0.54 on 2026-08-14. The go-shop expiring 11:59pm ET 2026-08-27 is the only mechanism that can print… CCRN Cross Country Healthcare, Inc. LOW Situation settled: the Knox Lane take-private became effective 2026-07-21 at $13.25 cash, Nasdaq suspended trading that morning and filed Form 25 the same day. No listed security, no residual claim, no forward catalyst — any CCRN bar dated… CCXI Churchill Capital Corp XI LOW De-SPAC humanoid pure-play now maturing: Unitree's 2026-08-19 STAR debut (+487% close, ~$53B) lifted CCXI for one session before the move fully round-tripped — $17.07 on 2026-08-14 to $14.57 on 2026-08-21, RSI 73.4 to 43.5. Still no public… CMBT CMB.TECH NV LOW July's non-confirmation resolved upward: CMBT closed 2026-08-14 at $17.24, a 52-week high on the adjusted series, RSI 79.4, into a confirmed 2026-08-27 Q2 print whose rates were pre-disclosed on 2026-05-19 (81% of VLCC days at… CNMD CONMED Corporation LOW Six weeks on, the deal leg is still the only unresolved one: no process headline since 2026-07-10, no sell-side action since 2026-07-30, no company event dated inside 30 days — yet price drifted to $51.07 on 2026-08-21, 10.9% above the… CNTA Centessa Pharmaceuticals plc LOW Closed cash-plus-CVR takeout; nothing trades. Lilly's scheme ($38.00 cash plus a non-transferable CVR of up to $9.00) went effective 2026-06-24, Form 15-12G dated 2026-07-06. New since the last note: ClinicalTrials.gov lists a Phase… CPIX Cumberland Pharmaceuticals Inc. LOW Deal-arb thesis is now spent: the $100M Apotex asset sale closed 2026-07-01 after a 99.84% shareholder vote on 2026-06-24, so the dated binary that drove the ~3.2x off $1.85 to a $7.36 high is consumed. What remains is a cash-rich clinical… CRNX Crinetics Pharmaceuticals, Inc. LOW Not a narrative any more: the Vertex $85.00/share cash takeout cleared HSR on 2026-08-12, the stockholder vote is 2026-08-28, and closing is guided to early September. At the 2026-08-14 close of $84.70 the gap to terms is $0.30 against… CRTO Criteo S.A. LOW Takeover-premium leg is dead and the tape kept going: the 2026-07-06 Vista/Quinti gap is fully filled, no party has confirmed anything in 46 days, and the 2026-08-05 guide cut re-based FY26 contribution ex-TAC to $1.034–1.058B from… CXT Crane NXT, Co. LOW Beat-and-raise on 2026-08-05 has been fully sold: the ~$56.23 post-print quote gave way to a $50.20 close on 2026-08-21, RSI 39.3, and 2026-08-19 opened $48.06 with no company release behind it. Organic growth was only 2.8% of the 22%… DLTR Dollar Tree Inc. LOW Guide-raise leg resolves in four sessions: the 2026-08-27 Q2 print (8:00 a.m. ET call, Dollar General the same morning) is the binary. At the 2026-08-21 close of $131.48 the stock trades above both aggregated mean targets ($127.32 /… DNUT Krispy Kreme, Inc. LOW Attention returned before the fundamentals changed: BofA lifted its target to $4.90 on 2026-08-10 and the Pokémon collection hit shops 2026-08-18, carrying the close from $3.33 (08-14) to $3.59 (08-21) with RSI(14) at 69.9. The… EPC Edgewell Personal Care Company LOW Two legs: a refused $30 take-private approach (2026-06-22) and a first clean quarter (fiscal Q3 organic +1.1%, adjusted EPS $0.72 vs $0.62). Sixty days on there is no competing bid, no process and no 13D, and the shares have coiled within… ESPR Esperion Therapeutics, Inc. LOW Resolved and off the tape. ARCHIMED's take-private closed 2026-07-13 at $3.16 cash plus a non-tradeable CVR of up to $100M; Nasdaq was asked to file Form 25 the same day and reporting duties are being suspended by Form 15. The early-August… GBTG Global Business Travel Group, Inc. LOW Take-private in its final leg: stockholders adopted the $9.50 Long Lake merger on 2026-08-03, and the 2026-08-14 close of $9.46 leaves $0.04 gross against a roughly 37% break tail to the unaffected $5.93. Only undated offshore regulatory… GCO Genesco Inc. LOW The operating turnaround is real but priced, and its one asymmetric leg — the activist proxy fight — lost its teeth: ISS (2026-07-07) backed all nine board directors and urged holders to withhold from the two Radoff/Jumana nominees, so the… HELE Helen of Troy Limited LOW Deleveraging-stub leg broke out: 2026-08-14 close $30.22 is a 52-week closing high with no dated news behind it, above the $26.50 consensus target and both published targets. Forward P/E re-rated 7.55→8.25 on an unchanged $3.25–$3.75 FY27… IHRT iHeartMedia, Inc. LOW M&A leg is dead — no SiriusXM headline since the 2026-05-29 NYT "stalled" report and the April spike fully round-tripped ($6.33 high → $3.86 on 2026-08-07, -39%). What is left is a binary: Q2 print 2026-08-10 after the close is the first… IMRX Immuneering Corporation LOW Busted-catalyst pancreatic biotech: atebimetinib's 17.3-mo single-arm 1L OS is real, but the Phase 3 binary is mid-2028 and the tape keeps fading post-ASCO ($5.11→$4.32 in two weeks) even as targets climb to $18–$30. Cheap… IRWD Ironwood Pharmaceuticals, Inc. LOW Post-print drift: the 2026-08-06 binary resolved with FY26 guidance raised (revenue $460–485M, adjusted EBITDA above $310M) but both reported lines missing consensus, and two weeks on the stock is unchanged at $4.29, 20.4% under the $5.39… ITGR Integer Holdings Corporation LOW Signed-deal instrument since 2026-08-03: KKR's $127.00 all-cash agreement leaves $1.80 above the 2026-08-21 close of $125.20 (~1.4%), unchanged from two weeks earlier. The paperwork stage has begun with no paperwork — no merger proxy on… JACK Jack In The Box Inc. LOW June's move was a float mechanic — Russell Microcap inclusion (effective 2026-06-30) into a 40%-short float drove $8.92 to $18.13, and it is unwinding ($14.98 on 2026-07-17, -7.76%). SSS is genuinely inflecting (-6.7% → -3.8%), but price… KALV KalVista Pharmaceuticals, Inc. LOW Resolved cash takeout, not a live security: Chiesi's $27.00/share acquisition closed 2026-06-11, KALV delisted the same morning, Form 15-12G filed 2026-06-22, and Rule 12g-4 registration termination lands ~2026-09-20. The 2026-06-10 close… KURA Kura Oncology, Inc. LOW The binary already fired: KOMZIFTI's 2025-11-13 approval and ~40% R/R NPM1 share are priced, and the $24–28 targets need a frontline Phase 3 that doesn't read until 2028. The tape is drifting — $10.39, lower third of the H1 range. A… LAR Lithium Argentina AG LOW Commodity-beta bounce stopped transmitting: GFEX 2609 extended to CNY 156,140/t on 2026-08-22 while the shares went $6.82 (08-14) to $6.83 (08-21) and RSI cooled 66.8 to 58.6. Lithium-recovery narrative reads saturated; two price targets… LILA Liberty Latin America Ltd. LOW Break-up leg intact but the news flow has flipped from company action to downgrades: Morgan Stanley cut to Underweight $7.00 on 2026-08-20, leaving the 2026-08-21 close of $8.47 above all three dated targets ($6.50/$7.00/$8.00). RSI 51.9… LILAK Liberty Latin America Ltd. LOW Post-catalyst drift: the $500M preferred special dividend and the June Malone/Nair insider cluster already drove a ~70% run off $4.76 to ~$8.30, and the tape has stalled at $7.33. Citi cut to Neutral 2026-07-10 with a $8 target already… LNC Lincoln National Corp. LOW Legacy-risk-transfer re-rating: the 2026-07-30 Talcott deal cedes ~$5.8B of GUL statutory reserves for ~$200M all-in statutory capital, alongside a Q2 adjusted EPS beat at $2.24 vs $1.96. But the information is out, price sits 2.1% under… LPRO Open Lending Corporation LOW Terminal, not fading: ANV's $3.15 all-cash tender expired 2026-07-27 with ~85.65% tendered, shares accepted 2026-07-28, §251(h) merger consummated 2026-07-30. Last public close $3.14 on 2026-07-29. As of 2026-08-23 nothing has reopened it… MGM MGM RESORTS INTERNATIONAL LOW Take-private process went live: WSJ reported substantive Diller talks 2026-07-10, MGM seated a special committee mid-July, and the board reportedly views $48.30 as too low — so the trade is now a bump handicap, not a growth story. At… MKTX MarketAxess Holdings, Inc. LOW ICE's $167.00 all-cash agreement (signed 2026-07-30) has fully converted MKTX into a spread instrument, and the spread has drifted wider: $167.00 less the 2026-08-21 close of $162.11 leaves $4.89 gross against an H1 2027 guided close.… OGN Organon & Co. LOW Deal-pinned arb, now purely regulatory: the $14.00 all-cash Sun Pharma offer was approved by holders 2026-07-23 and the 2026-08-21 close of $13.75 leaves $0.25, ~1.8% gross, into a stated early-2027 close. Upside is capped by contract; a… OLPX Olaplex Holdings, Inc. LOW Closed by event and now confirmed from the buyer's side: Henkel's all-cash takeout completed 2026-07-07 at $2.06 per share, Nasdaq delisting and a Form 15-12G followed, and Henkel's 2026-08-06 half-year report carries no brand-level… OPI Office Properties Income Trust Common shares of beneficial interest LOW First post-reorg print landed 2026-08-05: 77.9% leased, $1.707B debt, the book equity, no dividend. The binary passed without breaking the tape — The narrative has matured from deleveraging re-rate into asset-sale arithmetic with insider… P Everpure, Inc. LOW Hyperscaler design-win re-rating has stalled: 52-week high $118.16 on 2026-08-14, then a 2026-08-21 close of $108.55 with RSI(14) still 79.5 while TD Cowen ($170) and Wedbush ($127) raised targets into the fall. The 2026-08-26 Q2 FY2027… PAYO Payoneer Global Inc. LOW Pure merger-arb, now fully scheduled: HSR early termination granted 2026-07-28 and the 2026-08-11 definitive proxy set the shareholder vote for 2026-09-14, yet the 2026-08-14 close of $7.13 still sits $0.27 under Nuvei's $7.40 all-cash… PBI Pitney Bowes Inc. LOW PBI broke the $17.62 shelf to a fresh 52-week high $18.62 (Jul 16) — the buyback/cost-cut re-rate is now extending, not consolidating. But revenue still shrinks ~3% YoY, consensus PT $16.43 sits below spot, and Q2 prints after close Jul… PII Polaris Inc. LOW The $66 shelf the recovery leg stood on is gone: the 2026-06-05 low of $66.06 broke and PII closed 2026-08-21 at $64.39, three weeks after a beat-and-raise (Q2 sales $2,023M, operational adjusted EPS $1.01 vs a $0.70–0.80 guide). The… PLTK Playtika Holding Corp. LOW The control-premium bid is gone and the markdown extended: the 2026-08-21 weekly close of $2.37 took out the $2.51 shelf, RSI(14) 12.9, 44.4% under the $4.26 52-week high. The one new disclosure is financing rather than a sale — 2026-08-18… RAMP LiveRamp Holdings, Inc. LOW Shareholder gate cleared 2026-08-17: 51,578,202 shares voted to adopt versus 60,073 against, leaving CFIUS, HSR and non-US clearances as the only unconfirmed conditions on Publicis' $38.50 cash offer. The 2026-08-21 close of $37.58 sits… REAX The Real Brokerage, Inc. fresh LOW Hypergrowth brokerage story has decelerated (Q1 rev +32% vs 70%+ historically, a forecast miss) and the stock sits near 52-week lows after the $880M RE/MAX deal spooked investors on dilution. The read is now a binary consolidation bet, not… RFAI RF Acquisition Corp II fresh LOW Near-total redemption — 3,956,323 of 3,998,108 public shares, 98.95% — left almost no tradable float into the 2026-08-19 Nanyang Biologics approval, and RFAI ran +524.3% on the week to close $58.00. The leg being bought is a mechanical… RLYB Rallybio Corporation LOW No new filing since the 2026-08-06 10-Q: as of 2026-08-23 the 2026-07-15 S-4 is still not effective, with no record date or meeting date set. The 2026-08-21 close of $16.83 sits ~7% above the ~$15.68/share implied by the S-4's $83.2M Net… RPAY Repay Holdings Corporation LOW The bid discount narrowed on an operating headline: the close ran $3.66 (2026-08-14) to $4.01 (2026-08-21) after REPAY joined Visa Platform Connect on 2026-08-19, leaving Forager's rejected $5.25 cash proposal ~31% above the tape with no… SEER Seer, Inc. LOW The take-private ladder has stalled into a stand-off: the $2.55 Radoff-JEC bid lapsed unanswered on 2026-08-10, and the group's 2026-08-13 release demanding the board disclose an evaluation timeline has drawn no company reply through the… SITM SiTime Corporation LOW MEMS-timing picks-and-shovels story is fundamentally intact — Q1 datacenter revenue +158% YoY to 67% of sales, Renesas timing deal closed July 1 — but the momentum leg has broken: ~$550 on July 18 is ~39% off the May 11 all-time-high close… SMTI Sanara MedTech Inc. LOW Merger-arb instrument since MIMEDX's 2026-07-29 agreement ($33.00 cash + 0.4735 MDXG per share). The 2026-08-11 Form 425 disclosed a 2027-07-29 outside date, a $22.5M reverse termination fee and 38.9% voting lock-up; at the $34.45 close… STAA STAAR Surgical Company LOW Structure broken, no dated catalyst before the ~2026-10-07 pre-release window. SYNA Synaptics Incorporated LOW Standalone story ended at the 2026-06-25 all-stock takeout; The week to 2026-08-21 proved it — ON -10.2%, SYNA -10.1%, discount still ~2.5% (1.350 x $74.21 = $100.18 vs $97.66). The S-4 filed 2026-08-21 puts the vote on the clock and… TBRG TruBridge, Inc. LOW Closed and now formally deregistered: the IKS Health merger became effective 2026-07-09 at $26.25/share cash, Form 25 filed the same day, Form 15-12G on 2026-07-24. The adjusted series ends 2026-07-08 at $26.24. A screen still surfacing… TECH Bio-Techne Corp LOW Closed merger-arb pinned $0.60 under Merck KGaA's $73.00 all-cash bid — 2026-08-14 close $72.40, also the 52-week high. Q4 printed 08-12 with no call and no FY27 guidance; Wells Fargo folded to a $73 target on 08-13. Coverage is fully… TIC TIC Solutions, Inc LOW Post-merger re-rate: engineering/geospatial backlog hit a record $1.18B (+20% YoY) on 2026-08-06 while legacy inspection fell ~5.5% combined, and UBS's 2026-08-11 upgrade (Buy, PT $12.50 from $11.00) prices an inflection that Q2's +2.5%… TORO Toro Corp. LOW Panagiotidis shipping shell (NOT lawnmower TTC) ran 1.93→8.50 on a sub-NAV/special-dividend story that is now fully paid out and closed. Six weeks of dead tape since the 2026-06-05 payout ($3.8M cash + 5,707,246 NEW shares); on a true… TRIP TripAdvisor, Inc. LOW Activist sum-of-the-parts leg broke: Q2 revenue $441.9M missed consensus $503.9M on 2026-08-06 (~-20% day), four targets cut to $9–$12.50 by 08-11, and the $11–13 base gave way to a $10.74 close on 2026-08-14 with RSI 25. What's left is an… UNIT Uniti Group Inc. LOW Hyperscaler dark-fiber demand turned the post-Windstream deleveraging grind into a growth story (~$1.5B disclosed funnel, $68.7M of Q1 IRU revenue from one hyperscaler), but the June re-rate to ~$11 has stalled in a three-week range above… VECO Veeco Instruments Inc. LOW Merger-arb tracking stock for Axcelis: fixed 0.3575 ACLS/VECO, both votes cleared 2026-02-06, only China SAMR remains before the 2026-09-30 outside date. ACLS's slide to ~$134 de-pegged VECO to a premium over the exchange ratio (~$48) —… WLFC Willis Lease Finance Corporation LOW Engine-leasing supercycle still printing records (Q1 rev +23%, EPS $4.03 vs $3.02 est), but the theme is maturing and the stock has faded ~18% off its 2026-07-06 ATH into the now-completed 3-for-1 split. The event stack has collapsed to… WSC WillScot Holdings Corporation LOW Cyclical modular-space leasing recovery with a small data-center kicker and an activist/M&A floor, but range-bound and digesting: shares drifted to ~$26 under the $31.88 high after the 2026-06-27 Russell growth-index removal. The confirmed… XHG XChange TEC.INC LOW Sub-$1 China insurance ADS re-rated ~4x in two sessions on a 2026-08-13 non-binding LOI to acquire HK AI insurtech First Cycle — terms undisclosed, subject to definitive agreements. The leg being bought is an AI-insurance pivot; the FY2025… XRX Xerox Holdings Corporation LOW Distressed-deleveraging special situation that round-tripped its June activist pop into a binary 2026-07-30 Q2 print. At ~$2.60 it sits below the $2.75 Hold consensus and inside the $2.25–$2.50 target band; anchor buyer STARTEEPO (8.8M sh,… XTLB XTL Biopharmaceuticals Ltd. LOW Delisting binary fully resolved — Nasdaq confirmed compliance 2026-07-20 — and the pivot pop has bled off: no dated company release since, ADS $2.94 (2026-07-25) → $2.79 (2026-08-14), RSI 44.4. Event narrative is saturated; the next leg…